Birdwatch Note Rating
2024-08-14 00:36:08 UTC - NOT_HELPFUL
Rated by Participant: 116AA7563BB4AFBEDF64912AC11B91817592AC7AAE08C3279973BD07807ED3AD
Participant Details
Original Note:
The scholarly articles have report "...These results suggest that a third dose of BNT162b2 is safe, improves humoral immunity against SARS-CoV-2, and could be immunologically beneficial for cancer patients on active chemotherapy." : https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9004706/ A scientific study is needed NOT speculation
All Note Details